These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Functional alterations of cardiac proteasomes under physiological and pathological conditions. Tsukamoto O; Minamino T; Kitakaze M Cardiovasc Res; 2010 Jan; 85(2):339-46. PubMed ID: 19684034 [TBL] [Abstract][Full Text] [Related]
5. Protein degradation and protection against misfolded or damaged proteins. Goldberg AL Nature; 2003 Dec; 426(6968):895-9. PubMed ID: 14685250 [TBL] [Abstract][Full Text] [Related]
6. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. Tsukamoto O; Minamino T; Okada K; Shintani Y; Takashima S; Kato H; Liao Y; Okazaki H; Asai M; Hirata A; Fujita M; Asano Y; Yamazaki S; Asanuma H; Hori M; Kitakaze M Biochem Biophys Res Commun; 2006 Feb; 340(4):1125-33. PubMed ID: 16403436 [TBL] [Abstract][Full Text] [Related]
7. Cardiac remodeling: UPS lost in transit. Razeghi P; Taegtmeyer H Circ Res; 2005 Nov; 97(10):964-6. PubMed ID: 16284188 [No Abstract] [Full Text] [Related]
8. The ubiquitin-proteasome system in cardiomyopathies. Schlossarek S; Carrier L Curr Opin Cardiol; 2011 May; 26(3):190-5. PubMed ID: 21415726 [TBL] [Abstract][Full Text] [Related]
9. Protein quality control in Alzheimer's disease by the ubiquitin proteasome system. de Vrij FM; Fischer DF; van Leeuwen FW; Hol EM Prog Neurobiol; 2004 Dec; 74(5):249-70. PubMed ID: 15582222 [TBL] [Abstract][Full Text] [Related]
10. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575 [TBL] [Abstract][Full Text] [Related]
11. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Paul S Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370 [TBL] [Abstract][Full Text] [Related]
12. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease. Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740 [TBL] [Abstract][Full Text] [Related]
14. The bitter end: the ubiquitin-proteasome system and cardiac dysfunction. Patterson C; Ike C; Willis PW; Stouffer GA; Willis MS Circulation; 2007 Mar; 115(11):1456-63. PubMed ID: 17372187 [TBL] [Abstract][Full Text] [Related]
15. Into the heart: the emerging role of the ubiquitin-proteasome system. Willis MS; Patterson C J Mol Cell Cardiol; 2006 Oct; 41(4):567-79. PubMed ID: 16949602 [TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases. Wang J; Maldonado MA Cell Mol Immunol; 2006 Aug; 3(4):255-61. PubMed ID: 16978533 [TBL] [Abstract][Full Text] [Related]
17. Role of the proteasome in ethanol-induced liver pathology. Donohue TM; Cederbaum AI; French SW; Barve S; Gao B; Osna NA Alcohol Clin Exp Res; 2007 Sep; 31(9):1446-59. PubMed ID: 17760783 [TBL] [Abstract][Full Text] [Related]
18. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. Sarikas A; Carrier L; Schenke C; Doll D; Flavigny J; Lindenberg KS; Eschenhagen T; Zolk O Cardiovasc Res; 2005 Apr; 66(1):33-44. PubMed ID: 15769446 [TBL] [Abstract][Full Text] [Related]